LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing ...

Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications. The Food and Drug Administration (FDA) has approved the supplemental New Drug Applications (sNDAs) for ...

PureTech Health has spied an opportunity to improve on Jazz Pharmaceuticals’ Epidiolex. Armed with its Glyph chemistry platform, the biotech has created an oral capsule formulation of cannabidiol (CBD ...

Dose normalized exposures following once daily administration of PAS-004 tablets were approximately 3-fold higher than those following administration with the capsule formulation, resulting in the 8mg ...

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (ACAD) today announced that the U.S. District Court for the District of Delaware ruled in favor of Acadia regarding its ‘721 formulation patent ...

The tablet formulation of Brukinsa is supplied as a 160mg dose, allowing patients the convenience of taking only 2 tablets daily. The Food and Drug Administration (FDA) has approved a new tablet ...

A new independent analysis examines Laellium, a Florida-based dietary supplement manufacturer, and consumer interest in bariatric gelatin-inspired metabolic support formulations as search volume for ...

A phase 3 randomized clinical trial has recently been conducted to investigate the efficacy of a capsule formulation (CVO PLUS CURATIF) in treating mild-to-moderate coronavirus disease 2019 (COVID-19) ...